Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients
出版年份 2022 全文链接
标题
Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients
作者
关键词
-
出版物
HEPATOLOGY RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-01-28
DOI
10.1111/hepr.13749
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improving the prediction of relapse after nucleos(t)ide analogue discontinuation in patients with chronic hepatitis B
- (2021) Do Seon Song et al. CLINICAL INFECTIOUS DISEASES
- The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analog therapy
- (2021) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
- (2021) Takako Inoue et al. JOURNAL OF HEPATOLOGY
- Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL
- (2020) Tzu-Ning Tseng et al. Clinical Gastroenterology and Hepatology
- Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir therapy
- (2020) Shao-Ming Chiu et al. Clinical Gastroenterology and Hepatology
- Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study
- (2020) Minseok Albert Kim et al. GUT
- Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma
- (2020) Shigeru Kusumoto et al. JOURNAL OF HEPATOLOGY
- Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
- (2020) Wai-Kay Seto et al. GUT
- Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy
- (2020) Yayun Liu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Hepatitis B surface antigen, core‐related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation
- (2020) Apichat Kaewdech et al. LIVER INTERNATIONAL
- Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B
- (2020) Maria Pfefferkorn et al. JOURNAL OF HEPATOLOGY
- Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
- (2020) Milan J. Sonneveld et al. Clinical Gastroenterology and Hepatology
- Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
- (2020) Mireia García-López et al. JOURNAL OF HEPATOLOGY
- Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
- (2019) Hariklia Kranidioti et al. JOURNAL OF VIRAL HEPATITIS
- Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
- (2019) Rong Fan et al. Clinical Gastroenterology and Hepatology
- A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum
- (2019) Ming Gao et al. ARCHIVES OF VIROLOGY
- Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysis
- (2019) Yun Liu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance
- (2019) Yali Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Predictors of HBsAg loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in non‐cirrhotic HBeAg‐negative chronic hepatitis B
- (2019) Margarita Papatheodoridi et al. JOURNAL OF VIRAL HEPATITIS
- Pre‐genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy
- (2019) Ivana Carey et al. HEPATOLOGY
- 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
- (2019) Li Gao et al. Annals of Hepatology
- Genetic variations in the CXCR5 gene decrease the risk of clinical relapse after discontinuation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B
- (2019) Yin Wu et al. INFECTION GENETICS AND EVOLUTION
- Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
- (2018) S. Van Hees et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
- (2018) Conar R. O'Neil et al. Annals of Hepatology
- Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy
- (2018) Heng Chi et al. Clinical Gastroenterology and Hepatology
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
- (2018) Laura Rivino et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy
- (2018) Ming-Te Kuo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
- (2018) Franziska Rinker et al. JOURNAL OF HEPATOLOGY
- Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
- (2018) Hung-Chih Yang et al. JOURNAL OF HEPATOLOGY
- Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy
- (2018) Tung-Hung Su et al. JOURNAL OF INFECTIOUS DISEASES
- The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients
- (2018) C.-H. Chen et al. JOURNAL OF VIRAL HEPATITIS
- Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B
- (2018) Florian van Bömmel et al. LIVER INTERNATIONAL
- Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
- (2018) Yao-Chun Hsu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation among Asian Chronic Hepatitis B Patients: A Systematic Review
- (2018) Jiaye Liu et al. HEPATOLOGY
- Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
- (2017) Jie Wang et al. JOURNAL OF HEPATOLOGY
- Serum HBV pgRNA as a clinical marker for cccDNA activity
- (2017) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
- (2017) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study
- (2017) Jiawei Cao et al. JOURNAL OF INFECTIOUS DISEASES
- Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
- (2017) Cheng-Hao Tseng et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy
- (2017) C.-H. Hung et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
- (2017) Danny Ka-Ho Wong et al. LIVER INTERNATIONAL
- Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
- (2017) Chih-Chien Yao et al. Scientific Reports
- Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
- (2016) Chia-Chi Wang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
- (2016) Yao-Chun Hsu et al. Clinical Gastroenterology and Hepatology
- Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen–Negative Patients
- (2016) Wen-Juei Jeng et al. Clinical Gastroenterology and Hepatology
- Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
- (2016) George Papatheodoridis et al. HEPATOLOGY
- Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients
- (2016) Yuan-wang Qiu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
- (2016) Jie Wang et al. JOURNAL OF HEPATOLOGY
- Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study
- (2016) Seong Hee Kang et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis
- (2015) Y. C. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection
- (2015) Chien-Hung Chen et al. Clinical Gastroenterology and Hepatology
- Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients
- (2015) H.-Y. Pan et al. CLINICAL MICROBIOLOGY AND INFECTION
- Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
- (2015) Tse-Ling Fong et al. DIGESTIVE DISEASES AND SCIENCES
- Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
- (2015) Rong Fan et al. GUT
- Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B
- (2015) Carolina Boni et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs
- (2015) Jian-ning Jiang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
- (2015) Kyu Sik Jung et al. JOURNAL OF GASTROENTEROLOGY
- Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate
- (2015) G. Papatheodoridis et al. JOURNAL OF VIRAL HEPATITIS
- Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
- (2015) I-Cheng Lee et al. MEDICINE
- Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients
- (2015) Guo-Hong Ge WORLD JOURNAL OF GASTROENTEROLOGY
- Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B
- (2015) Jie Peng et al. Saudi Journal of Gastroenterology
- Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides
- (2014) V. R. Patwardhan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
- (2014) Wai-Kay Seto et al. GUT
- Distinct seromarkers predict different milestones of chronic hepatitis B progression
- (2014) Jessica Liu et al. HEPATOLOGY
- The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment
- (2014) Chien-Hung Chen et al. JOURNAL OF HEPATOLOGY
- Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System
- (2014) J. Liu et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of Serum Cytokine Profiles Associated with HBeAg Seroconversion Following Antiviral Treatment Interruption
- (2014) Shilpa Chokshi et al. VIRAL IMMUNOLOGY
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
- (2013) Masataka Tsuge et al. JOURNAL OF GASTROENTEROLOGY
- Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
- (2013) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
- (2012) Quan Yuan et al. GUT
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
- (2012) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection
- (2012) Jessica Liu et al. JOURNAL OF HEPATOLOGY
- Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients
- (2012) Young-Joo Jin et al. Virology Journal
- Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B
- (2012) Myeong Jun Song WORLD JOURNAL OF GASTROENTEROLOGY
- Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
- (2011) Y. Liang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
- (2011) Henry L-Y Chan et al. ANTIVIRAL THERAPY
- Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
- (2011) Jerzy Jaroszewicz et al. ANTIVIRAL THERAPY
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- (2011) Akihiro Matsumoto et al. HEPATOLOGY RESEARCH
- Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
- (2009) Chau-Ting Yeh et al. JOURNAL OF CLINICAL VIROLOGY
- Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
- (2009) L. Wang et al. JOURNAL OF VIRAL HEPATITIS
- Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients
- (2008) Fumitaka Suzuki et al. JOURNAL OF MEDICAL VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started